Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Venetoclax in Combination with Hypomethylating Agents for the Treatment of High-Risk Myelodysplastic Syndromes–Real-World Analyses

Jian Zhang, Yang Xu, Zhihong Lin, Jun Chen, Limin Liu, Depei Wu, Huiying Qiu

Blood (2024) 144 (Supplement 1): 6732.

https://doi.org/10.1182/blood-2024-199990

Published: 2024

Journal Articles

Efficacy and Safety of Gilteritinib-Based Therapy Combinated with Allo-HSCT in Relapsed or Refractory Acute Myeloid Leukemia Patients with Positive FLT3-ITD Mutation

Jian Zhang, Yang Xu, Shengli Xue, Miao Miao, Ying Wang, Suning Chen, Depei Wu, Huiying Qiu

Blood (2024) 144 (Supplement 1): 6079.

https://doi.org/10.1182/blood-2024-198895

Published: 2024

Journal Articles

Long-Term Remission and Survival in Patients with Rituximab-Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Treatment with U16 (CD20 CAR-T cells)

Qian Cheng, JingWen Tan, Rui Liu, Liqing Kang, Hongjia Zhu, Yi Zhang, Erhua Wang, Ying Li, Jian Zhang, Han Xiao, Rong He, Xiaoyan Lou, Nan Xu, Wei Wang, Zhou Yu, Minghao Li, Hongfei Gu, Lei Yu, Xin Li

Blood (2024) 144 (Supplement 1): 3447.

https://doi.org/10.1182/blood-2024-200516

Published: 2024

Journal Articles

Linker Histone Regulates the Myeloid Versus Lymphoid Bifurcation of Multipotent Hematopoietic Stem and Progenitors

Shangqin Guo, Kutay Karatepe, Bruna Mafra De Faria, Jian Zhang, Xinyue Chen, Anna Eastman

Blood (2024) 144 (Supplement 1): 434.

https://doi.org/10.1182/blood-2024-211935

Published: 2024

Journal Articles

Safety and Efficacy in Patients with Advanced Lymphomas from a Global Phase 1a/1b, First-in-Human Study of CS5001, a Novel Anti-ROR1 ADC

Blood (2024) 144 (Supplement 1): 1739.

https://doi.org/10.1182/blood-2024-192979

Published: 2024

Journal Articles

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Blood (2024) 144 (14): 1471–1485.

https://doi.org/10.1182/blood.2024023883

Published: 2024

Includes: Supplemental data

Journal Articles

Trinary Fusion with Ligand Binding Domain Castration Is Crucial in Rarg -Driven APL and Render Unresponsive to ATRA Via Allosteric Disability Mechanism

Blood (2023) 142 (Supplement 1): 2949.

https://doi.org/10.1182/blood-2023-185483

Published: 2023

Journal Articles

Development of Best-in-Class Gene Editing Therapy for β-Hemoglobinopathies Using Innovative Transformer Base Editor (tBE)

Blood (2023) 142 (Supplement 1): 5243.

https://doi.org/10.1182/blood-2023-178440

Published: 2023

Journal Articles

Selinexor in Combination with Hypomethylating Agent (HMA) in Patients with Refractory/Relapsed Acute Myeloid Leukemia (AML) Previously Exposed to Venetoclax: A Retrospective Study

Jian Zhang, Baoquan Song, Yin Liu, De-Pei Wu, Huiying Qiu

Blood (2023) 142 (Supplement 1): 5947.

https://doi.org/10.1182/blood-2023-182665

Published: 2023

Journal Articles

Selinexor and Chidamide in Patients with Relapsed/Refractory Acute Myeloid Leukemia Exposed to Venetoclax: A Single-Arm, Phase 2 Study

Jian Zhang, Baoquan Song, Yin Liu, Yanjun Wu, De-Pei Wu, Huiying Qiu

Blood (2023) 142 (Supplement 1): 5950.

https://doi.org/10.1182/blood-2023-185770

Published: 2023

Journal Articles

shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia

Liqing Kang, Xiaowen Tang, Nan Xu, Minghao Li, Jingwen Tan, Wei Qi, Zhou Yu, Xiaoyan Lou, Shengli Xue, Xin Li, MD, Jian Zhang, MD, Jia Chen, MD, Zhenkun Wang, PhD, Caixia Li, Fu Cheng Cheng, MD PhD, Depei Wu, MD PhD, Lei Yu, MD PhD

Blood (2019) 134 (Supplement_1): 2621.

https://doi.org/10.1182/blood-2019-132067

Published: 2019

Journal Articles

The Lysine Histone Methyltransferase SETD2 Is Required for Appropriate Immunoglobulin VDJ Recombination

S. Haihua Chu, PhD, Jonathan Chabon, BS, Janna Minehart, BS, Chloe N Matovina, BS, Jian Zhang, Bo-Ruei Chen, PhD, Elsa Callen-Moreu, PhD, Putzer J Hung, Zhaohui Feng, BM, BS, Richard Koche, PhD, X. Shirley Liu, Jayanta Chaudhuri, Andre Nussenzweig, PhD, Barry Sleckman, Scott A. Armstrong, MD PhD

Blood (2018) 132 (Supplement 1): 511.

https://doi.org/10.1182/blood-2018-99-111952

Published: 2018

Journal Articles

Early Different Downstream Target of Glucocorticoid Receptor Contributing to Glucocorticoids Sensitivity in Kasumi-1 Cells

Wenbin Gu, Meng Li, Liang Liang, Jian Zhang, Chongye Guo, Zhikai Xing, Yongqing Lan, Sha Li, Yangyang Li, Ran Gao, Shuangli Mi

Blood (2016) 128 (22): 5132.

https://doi.org/10.1182/blood.V128.22.5132.5132

Published: 2016

Journal Articles

Cartilage oligomeric matrix protein is a natural inhibitor of thrombin

Ying Liang, Yi Fu, Ruomei Qi, Meili Wang, Nan Yang, Li He, Fang Yu, Jian Zhang, Cai-Hong Yun, Xian Wang, Junling Liu, Wei Kong

Blood (2015) 126 (7): 905–914.

https://doi.org/10.1182/blood-2015-01-621292

Published: 2015

Includes: Supplemental data

Journal Articles

Impaired Platelet Responses to Thromboxane a 2 and Thrombin in Mice Lacking Receptor-Interacting Protein Kinase 3

Yiwen Zhang, PhD, Jian Zhang, PhD, Rong Yan, PhD, Jie Zhang, PhD, Mengxing Chen, Miao Jiang, PhD, Zhenyu Li, MD PhD, Changgeng Ruan, Sudan He, PhD, Kesheng Dai

Blood (2014) 124 (21): 2762.

https://doi.org/10.1182/blood.V124.21.2762.2762

Published: 2014

Journal Articles

A Phase II Study of Low Dose Intravenous Clofarabine for Elderly Myelodysplastic Syndrome Patients Who Have Failed 5-Azacytidine

Seah H Lim, MD, PhD, John McMahan, RN, Jian Zhang, BS, Yana Zhang, MD, PhD

Blood (2010) 116 (21): 4955.

https://doi.org/10.1182/blood.V116.21.4955.4955

Published: 2010

Journal Articles

Clofarabine Induces Hypomethylation of DNA and Expression of Cancer-Testis Antigens

Yana Zhang, MD, PhD, Jian Zhang, BA, Masum Shahriar, MSc, Seah H. Lim, MD, PhD

Blood (2008) 112 (11): 379.

https://doi.org/10.1182/blood.V112.11.379.379

Published: 2008

Journal Articles

Semg 1 Expression in Early Chronic Lymphocytic Leukemia

Farouk Meklat, BS, Sharif Uddin Ahmed, PhD, Masum Shahriar, MSc, Jian Zhang, BA, Suhkrob Mastulov, MD, Thomas Giannakouros, PhD, Andrew Jewell, PhD, Yana Zhang, MD, PhD, Seah H. Lim, MD, PhD

Blood (2008) 112 (11): 4175.

https://doi.org/10.1182/blood.V112.11.4175.4175

Published: 2008

Journal Articles

Expression of the Cancer-Testis Antigens, SEMG 1 and Protamine 1, in Early CLL: Their Relationship to Disease Stage and Zap 70 Expression.

Farouk Meklat, BS, Yana Zhang, MD, PhD, Zhiqing Wang, PhD, Jian Zhang, BS, Sukhrob Mustalov, MD, Andrew P. Jewell, PhD, Seah H. Lim, MD, PhD

Blood (2007) 110 (11): 4680.

https://doi.org/10.1182/blood.V110.11.4680.4680

Published: 2007

Journal Articles

B-Cell Depletion for Two Years after Autologous Stem Cell Transplant Reduces Lymphoma Relapse but Induces Prolonged Hypogammaglobulinemia beyond the Rituxan Maintenance Period.

Seah H. Lim, MD, PhD, William V. Esler, MD, Yana Zhang, MD. PhD, Jian Zhang, BS, Phillip O. Periman, MD, Colleen Burris, RN, OCN, Mary Townsend, MD

Blood (2007) 110 (11): 4480.

https://doi.org/10.1182/blood.V110.11.4480.4480

Published: 2007

NARROW

Efficacy and Safety of Venetoclax in Combination with Hypomethylating Agents for the Treatment of High-Risk Myelodysplastic Syndromes–Real-World Analyses

Efficacy and Safety of Gilteritinib-Based Therapy Combinated with Allo-HSCT in Relapsed or Refractory Acute Myeloid Leukemia Patients with Positive FLT3-ITD Mutation

Long-Term Remission and Survival in Patients with Rituximab-Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Treatment with U16 (CD20 CAR-T cells)

Linker Histone Regulates the Myeloid Versus Lymphoid Bifurcation of Multipotent Hematopoietic Stem and Progenitors

Safety and Efficacy in Patients with Advanced Lymphomas from a Global Phase 1a/1b, First-in-Human Study of CS5001, a Novel Anti-ROR1 ADC

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Trinary Fusion with Ligand Binding Domain Castration Is Crucial in Rarg -Driven APL and Render Unresponsive to ATRA Via Allosteric Disability Mechanism

Development of Best-in-Class Gene Editing Therapy for β-Hemoglobinopathies Using Innovative Transformer Base Editor (tBE)

Selinexor in Combination with Hypomethylating Agent (HMA) in Patients with Refractory/Relapsed Acute Myeloid Leukemia (AML) Previously Exposed to Venetoclax: A Retrospective Study

Selinexor and Chidamide in Patients with Relapsed/Refractory Acute Myeloid Leukemia Exposed to Venetoclax: A Single-Arm, Phase 2 Study

shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia

The Lysine Histone Methyltransferase SETD2 Is Required for Appropriate Immunoglobulin VDJ Recombination

Early Different Downstream Target of Glucocorticoid Receptor Contributing to Glucocorticoids Sensitivity in Kasumi-1 Cells

Cartilage oligomeric matrix protein is a natural inhibitor of thrombin

Impaired Platelet Responses to Thromboxane a 2 and Thrombin in Mice Lacking Receptor-Interacting Protein Kinase 3

A Phase II Study of Low Dose Intravenous Clofarabine for Elderly Myelodysplastic Syndrome Patients Who Have Failed 5-Azacytidine

Clofarabine Induces Hypomethylation of DNA and Expression of Cancer-Testis Antigens

Semg 1 Expression in Early Chronic Lymphocytic Leukemia

Expression of the Cancer-Testis Antigens, SEMG 1 and Protamine 1, in Early CLL: Their Relationship to Disease Stage and Zap 70 Expression.

B-Cell Depletion for Two Years after Autologous Stem Cell Transplant Reduces Lymphoma Relapse but Induces Prolonged Hypogammaglobulinemia beyond the Rituxan Maintenance Period.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only